Sarah Ketterer - Causeway Capital Management
Holding/activity history for Novo Nordisk A/S (NVO)
← All NVO superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 1,174,213 | 0.53 | Add 18.15% | 0.08 | $35.12–64.16 · VW $45.34i | $43,152,333 | SEC |
| 2025 Q4 | 993,850 | 0.70 | Add 42.80% | 0.21 | $43.08–60.90 · VW $51.62i | $50,567,080 | SEC |
| 2025 Q3 | 695,979 | 0.51 | Add 96.67% | 0.25 | $45.05–71.80 · VW $57.45i | $38,619,855 | SEC |
| 2025 Q2 | 353,884 | 0.39 | Buy | 0.39 | $57.00–81.44 · VW $69.15i | $24,425,058 | SEC |
Price snapshot:
Current price$49.28
Avg. buy price$55.52
+/- since buy-11.24%
52-week low$34.58
52-week high$68.49